February 2017 Vol 10, No 1
Kumar Mukherjee, PhD; Khalid M. Kamal, PhD
Understanding Patients’ Demographics Is Key to Improving Clinical and Economic Healthcare Outcomes
F. Randy Vogenberg, RPh, PhD
Christopher B. Atzinger, MS, PhD candidate; Jeff J. Guo, BPharm, PhD
Rheumatoid Arthritis, Biologic Drugs, and Associated Cost
Byron C. Scott, MD, MBA
Joseph Lee, PhD; Ryan Pelkey, MS; Julieanna Gubitosa, BS; Michael F. Henrick, MBA;
Michael L. Ganz, MS, PhD
Identifying the Most Clinically and Economically Effective Therapies for Rheumatoid Arthritis Remains a Challenge for Providers and Payers
Gary Branning, MBA
Results 1 - 6 of 6